MedTrace Logo

S1 Transforaminal Injection and Vascular Incidence

NCT04634955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2022-12-20

No results posted yet for this study

Summary

Intravascular incidence during S1 transforaminal injection is known to be higher than lumbar injection. Its incidence is reported to be 15\~25%.

This study was aimed to see if there is any benefit of reducing the intravasuclar injection rate when S1 transforaminal injection was performed by different fluorosopic approach.

Conditions

  • Inadvertent Arterial Puncture

Interventions

PROCEDURE

tranforaminal epidural injection

tranforaminal epidural injection which is performed by fluoroscopic guidance

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Principal Investigators

  • Ji Hee Hong, PhD · Keimyung University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2021-04-15
Completion
2021-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04634955 on ClinicalTrials.gov